
Type-species-anchored Parabacteroides reconstruction showing eleven short-to-medium rods in five single and three paired groupings. This genus plate is representative, non-universal, non-diagnostic, not visually separable from a species plate, and not a micrograph.
Scientific media record1 verified identifier
- Subject
- Parabacteroidestaxon · genus
- Identifiers
- NCBITaxon:375288
- Review
- Editorial review completeIdentifiers authority-verified · Accessibility validated · · parabacteroides|parabacteroides-morphology-v1.webp
- Digital source
- Trained-algorithmic mediaCreated with a trained generative algorithm and reviewed by WikiBiome for subject identity, scientific framing, identifiers, provenance, and accessibility.
- Scientific basis
- Parabacteroides — NCBI TaxonomyParabacteroides — LPSNParabacteroides gen. nov. and reclassificationsParabacteroides distasonis type strain
- License
- CC BY-SA 4.0Created
A Gram-negative, obligate anaerobic genus within the Bacteroidetes phylum, closely related to Bacteroides fragilis. The best-characterized species, P. distasonis, has emerged as a key anti-inflammatory commensal with significant roles in bile acid metabolism and metabolic health.
Parabacteroides shows a distinctive pattern of being depleted in metabolic and autoimmune diseases while enriched in certain cancers, making it part of the "opposite directionality" signature described across disease categories.
Evidence map7 cited passagesInspect provenance +
Significantly depleted in graves disease alongside bacteroides fragilis and alistipes, contributing to the pro-inflammatory gut environment that drives thyroid autoimmunity.
Decreased in multiple sclerosis at baseline; B-cell depletion therapy (ocrelizumab) further reduces Parabacteroides as the overall microbiome shifts toward Firmicutes restoration.
Shows true opposite directionality in the Islam 2022 meta-analysis: increased in cancer cohorts but decreased in autoimmune disease cohorts.
Enriched in colorectal cancer progression—identified among genera contributing to CRC stage advancement alongside Proteus and alistipes.
Mendelian randomization evidence supports causal relationships between Parabacteroides abundance and circulating lipid profiles, consistent with its role in bile acid-mediated lipid homeostasis.
Parabacteroides abundance is associated with premenstrual symptom patterns in reproductive-age women, implicating it in the gut-brain-hormone axis of PMS/pmdd.
Altered Parabacteroides abundance identified in the fibromyalgia gut microbiome signature, consistent with its broader pattern of depletion in inflammatory and pain-associated conditions.
Role in Gut Ecosystem#
Member of the core Bacteroidetes community that dominates the human colon, contributing to polysaccharide degradation and bile acid biotransformation.
P. distasonis deconjugates primary bile acids and produces secondary bile acids including lithocholic acid, influencing Farnesoid X Receptor (FXR) and TGR5 signaling pathways that regulate immune tone and metabolic homeostasis.
Produces Short-Chain Fatty Acids (SCFAs) (primarily succinate and acetate) that feed cross-feeding networks supporting Butyrate producers like Faecalibacterium prausnitzii. Contributes to colonization resistance against pathogens through niche competition and bile acid-mediated inhibition.
Disease Associations#
Metabolic Protection#
Depleted in obesity and Type 2 Diabetes, where its loss correlates with impaired bile acid signaling and metabolic Metal-Driven Inflammation. P. distasonis supplementation in mouse models improves glucose tolerance, reduces adiposity, and ameliorates hepatic steatosis via bile acid-FXR-FGF15 axis modulation.
Autoimmune Disease#
Significantly depleted in Graves' Disease alongside Bacteroides fragilis and Alistipes, contributing to the pro-inflammatory gut environment that drives thyroid autoimmunity.[1]Alteration in gut microbiota is associated with immune imbalance in Graves' diseaseSu X, Yin X, Liu Y et al. · 2020Open reference 1 ↓
Decreased in Multiple Sclerosis at baseline; B-cell depletion therapy (ocrelizumab) further reduces Parabacteroides as the overall microbiome shifts toward Firmicutes restoration.[2]B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patientsAlba Troci, Olga Zimmermann, Daniela Esser et al. · 2022Open reference 2 ↓
Cancer—Opposite Directionality#
Shows true opposite directionality in the Islam 2022 meta-analysis: increased in cancer cohorts but decreased in autoimmune disease cohorts.[3]Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysisMd Zohorul Islam, Melissa Tran, Tao Xu et al. · 2022Open reference 3 ↓
Enriched in Colorectal Cancer progression—identified among genera contributing to CRC stage advancement alongside Proteus and Alistipes.[4]Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature constructionJungang Liu, Xiaoliang Huang, Chuanbin Chen et al. · 2023Open reference 4 ↓
This paradox may reflect context-dependent bile acid metabolism: protective secondary bile acids in healthy mucosa versus tumor-promoting deoxycholic acid in the dysbiotic cancer microenvironment.
Lipid Metabolism#
- Mendelian randomization evidence supports causal relationships between Parabacteroides abundance and circulating lipid profiles, consistent with its role in bile acid-mediated lipid homeostasis.[5]Causality of the gut microbiome and atherosclerosis-related lipids: a bidirectional Mendelian Randomization studyDa Teng, Wenjuan Jia, Wenlong Wang et al. · 2024Open reference 5 ↓
Premenstrual and Mood Symptoms#
- Parabacteroides abundance is associated with premenstrual symptom patterns in reproductive-age women, implicating it in the gut-brain-hormone axis of PMS/Premenstrual Dysphoric Disorder.[6]Takeda 2022 — Gut Microbiota in Women with Premenstrual SymptomsTakashi Takeda, Kana Yoshimi, Sayaka Kai et al. · 2022Open reference 6 ↓
Fibromyalgia#
- Altered Parabacteroides abundance identified in the fibromyalgia Gut Microbiome signature, consistent with its broader pattern of depletion in inflammatory and pain-associated conditions.[7]Minerbi 2019 — Altered Microbiome Composition in FibromyalgiaMinerbi A, Gonzalez E, Brereton NJB et al. · 2019Open reference 7 ↓
Key Metabolites#
Secondary bile acids (lithocholic acid, ursodeoxycholic acid)—immunomodulatory via FXR/TGR5. Succinate—intermediate metabolite; fuel for cross-feeding networks. Acetate—contributes to gut barrier maintenance and systemic anti-inflammatory signaling.
Connections#
- Bacteroides fragilis—sister taxon within Bacteroidales; co-depleted in autoimmune disease
- Alistipes—co-depleted in Graves' disease; shared bile acid metabolic niche
- Colorectal Cancer—paradoxical enrichment in cancer despite anti-inflammatory properties
- Graves' Disease—depleted, contributing to immune imbalance
- Multiple Sclerosis—reduced at baseline in MS patients
- Type 2 Diabetes—depletion linked to metabolic inflammation
- Short-Chain Fatty Acids (SCFAs)—acetate producer; supports cross-feeding with butyrate producers
- Dysbiosis—its loss is a marker of both metabolic and autoimmune dysbiosis
- inflammation—anti-inflammatory via bile acid and SCFA signaling
References 8
Numbered by first appearance in the article, then reconciled with its declared source list.
- 1
Su X, Yin X, Liu Y et al. (2020). Alteration in gut microbiota is associated with immune imbalance in Graves' disease. EBioMedicine.
- 2
Alba Troci, Olga Zimmermann, Daniela Esser et al. (2022). B-cell-depletion reverses dysbiosis of the microbiome in multiple sclerosis patients. Scientific Reports.
- 3
Md Zohorul Islam, Melissa Tran, Tao Xu et al. (2022). Reproducible and opposing gut microbiome signatures distinguish autoimmune diseases and cancers: a systematic review and meta-analysis. Microbiome.
- 4
Jungang Liu, Xiaoliang Huang, Chuanbin Chen et al. (2023). Identification of colorectal cancer progression-associated intestinal microbiome and predictive signature construction. Journal of Translational Medicine.
- 5
Da Teng, Wenjuan Jia, Wenlong Wang et al. (2024). Causality of the gut microbiome and atherosclerosis-related lipids: a bidirectional Mendelian Randomization study. BMC Cardiovascular Disorders.
- 6
Takashi Takeda, Kana Yoshimi, Sayaka Kai et al. (2022). Takeda 2022 — Gut Microbiota in Women with Premenstrual Symptoms. PLOS ONE.
- 7
Minerbi A, Gonzalez E, Brereton NJB et al. (2019). Minerbi 2019 — Altered Microbiome Composition in Fibromyalgia. Pain.
- 8
Chin-Hee Song, Nayoung Kim, Ryoung Hee Nam et al. (2023). Anti-PD-L1 Antibody and/or 17beta-Estradiol Treatment Induces Changes in the Gut Microbiome in MC38 Colon Tumor Model. Cancer Research and Treatment.
Article network
Mentioned here 14
Pages linking here 9
Connect the evidence
Publicly readable discussion by ORCID-authenticated researchers. Questions, interpretation, methods, corrections, and new evidence stay attached to this record.
No discussion yet. Start with a precise question or a source-backed observation.
Activity and accepted changes
Accepted researcher context, editorial status, public discussion, and upstream Git revisions are shown together. Pending, declined, and withdrawn proposals remain private.
- published revision
Backfill gut microbiome concept links
Karen Pendergrass · +1 −1
Inspect exact Git diff ↗ - published revision
Backfill inflammation concept links
Karen Pendergrass · +2 −2
Inspect exact Git diff ↗ - published revision
massive wiki expansion: 149 stubs fixed, 100+ new pages, Rule 15 scan, keystone papers
WikiBiome Deploy Bot · +5 −5
Inspect exact Git diff ↗ - published revision
nightly maintenance: 94 stub demotions, 181 source_count fixes, 22 auto-discovered stubs, 5 adversarial audits, 3 boundary fixes, 3 evidence-level corrections
WikiBiome Deploy Bot · +1 −0
Inspect exact Git diff ↗ - published revision
Add 11 deepened microbe entities and 9 new OC/CVD/infertility source pages
WikiBiome Deploy Bot · +7 −1
Inspect exact Git diff ↗ - published revision
WikiBiome update — 2026-04-15 17:23
WikiBiome Deploy Bot · +0 −1
Inspect exact Git diff ↗ - published revision
wiki: bulk entity upgrades, new article pages, and site regeneration
WikiBiome Deploy Bot · +6 −0
Inspect exact Git diff ↗ - published revision
WikiBiome update — integrity fixes, metallomic diet pages, cross-condition analyses
WikiBiome Deploy Bot · +14 −7
Inspect exact Git diff ↗ - published revision
WikiBiome update — 2026-04-10 13:49
WikiBiome Deploy Bot · +57 −0
Inspect exact Git diff ↗

